Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Onconetix (ONCO)
NASDAQ:ONCO
Holding ONCO?
Track your performance easily
ONCO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.42 - $21.47
Previous Close$2.45
Volume125.33K
Average Volume (3M)687.47K
Market Cap
$20.32M
Enterprise Value$37.79M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$10.38M
Price to Earnings (P/E)―
Beta1.96
Next Earnings
May 10, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-98.12
Shares Outstanding8,294,116
10 Day Avg. Volume59,307
30 Day Avg. Volume687,468
Standard Deviation0.32
R-Squared0.35
Alpha-0.14
Financial Highlights & Ratios
Price to Book (P/B)-0.46
Price to Sales (P/S)13.88
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.80
Enterprise Value/Gross Profit-33.53
Enterprise Value/Ebitda-0.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Onconetix News
PremiumCompany Announcements
Onconetix Secures Funding to Enhance Operations and Growth
PremiumCompany Announcements
Onconetix Announces Reverse Split to Meet Nasdaq Standards
Ownership Overview
11.42% Insiders
0.89% Mutual Funds
<0.01% Other Institutional Investors
87.68% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ONCO FAQ
What was Onconetix’s price range in the past 12 months?
Onconetix lowest stock price was $2.42 and its highest was $21.46 in the past 12 months.
What is Onconetix’s market cap?
Currently, no data Available
When is Onconetix’s upcoming earnings report date?
Onconetix’s upcoming earnings report date is May 10, 2024 which is 186 days ago.
How were Onconetix’s earnings last quarter?
Currently, no data Available
Is Onconetix overvalued?
According to Wall Street analysts Onconetix’s price is currently Overvalued.
Does Onconetix pay dividends?
Onconetix does not currently pay dividends.
What is Onconetix’s EPS estimate?
Onconetix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Onconetix have?
Onconetix has 8,294,734 shares outstanding.
What happened to Onconetix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Onconetix?
Currently, no hedge funds are holding shares in ONCO
---
Onconetix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.59%
12-Months-Change
Fundamentals
Return on Equity
-256.01%
Trailing 12-Months
Asset Growth
99.90%
Trailing 12-Months
Company Description
Onconetix
The investment seeks to replicate, net of expenses, the CBOE S&P 500 BuyWrite Index.
The index is designed to measure the total rate of return of a hypothetical ¿buy-write¿, or ¿covered call¿, strategy on the S&P 500 Index. This strategy consists of a hypothetical portfolio consisting of a ¿long¿ position indexed to the S&P 500 Index and the sale of a succession of one-month, at- or slightly out-of-the-money S&P 500 Index call options that are listed on the Chicago Board Options Exchange.
---
ONCO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Advaxis
―
Northwest Biotherapeutics
―
Cyclacel Pharmaceuticals
―
ImmunoCellular Therapeutics
―
---